beyfortus
(nirsevimab)Sanofi Pasteur Inc.
Usage: BEYFORTUS is indicated for preventing Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season, and in children up to 24 months who are vulnerable to severe RSV disease during their second RSV season.